Dr. Timothy Haystead

Biography

Timothy Haystead is a professor in the Department of Pharmacology and Cancer Biology at Duke University and a member of the Duke Cancer Institute. His research focuses on the discovery and development of novel small molecule inhibitors that target purine-utilizing proteins implicated in various human diseases including cancer and inflammatory conditions. Haystead's lab has pioneered the development of a series of molecules targeting heat shock proteins (Hsp90, Hsp70) and other key proteins involved in oncogenic signaling. His work includes programs on the pharmacological properties of DAPK3 (ZIPK) and PIM kinases for their potential use in treating hypertension and as preventative measures for stroke-related reperfusion injury. In addition, he has developed a chemoproteomic strategy for the development of therapeutic agents and imaging molecules based on his inhibitors. Haystead obtained his Ph.D. from the University of Dundee in 1988 and has held multiple academic positions, contributing to significant advancements in cancer therapeutic strategies through innovative drug discovery methods.

Research Interests

Experience

Courses